BFM
CDLX icon

Boothbay Fund Management’s Cardlytics CDLX Stock Holding History

Boothbay Fund Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,000
Closed -$17.6M – 2289
2022
Q1 		$17.6M Buy
+32,000
New +$19.3M 0.41% 24

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's CDLX Position: Q4 2025 in Review

Boothbay Fund Management sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 3,066 shares — an estimated $74.5K sold.

Boothbay Fund Management first reported a position in CDLX in Q3 2025 and held it in 1 quarter. The position peaked at $74.5K in Q3 2025. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Boothbay Fund Management reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 3,066 Cardlytics shares in Q4 2025, an estimated $74.5K.
  • Boothbay Fund Management first reported a position in Cardlytics in Q3 2025 and held it in 1 quarter.
  • Boothbay Fund Management's Cardlytics position peaked at $74.5K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.